Arturo Molina

Arturo Molina

Company: Sutro Biopharma

Job title: Chief Medical Officer


Targeting Folate Receptor-α in Gynecologic Cancers & other Solid Tumours with the Novel Antibody-Drug Conjugate, STRO-002 2:45 pm

Review STRO-002 preclinical data (in vitro cytotoxicty and xenograft models) in ovarian, endometrial and other cancers Evaluate clinical outcomes data from the STRO-002-GM1 dose escalation and expansion cohorts Investigate ongoing clinical trials testing STRO-002 as a monotherapy and in combination with other agentsRead more

day: Track C - Day 1 - PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.